Macular dystrophies mimicking age-related macular degeneration

Progress in Retinal and Eye Research

Volumn 39, Issue , 2014, Pages 23-57

  Saksens, Nicole T M ^a   Fleckenstein, Monika ^b   Schmitz Valckenberg, Steffen ^b   Holz, Frank G ^b   den Hollander, Anneke I ^a   Keunen, Jan E E ^a   Boon, Camiel J F ^a,c,d   Hoyng, Carel B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Age related macular degeneration; AMD; Clinical characteristics; Differential diagnosis; Macular dystrophy; Retina

Indexed keywords

ADULT ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY; ANGIOID STREAK; AUTOSOMAL DOMINANT INHERITANCE; CENTRAL AREOLAR CHOROIDAL DYSTROPHY; CENTRAL SCOTOMA; CENTRAL SEROUS RETINOPATHY; COLOR VISION DEFECT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DOYNE HONEYCOMB RETINAL DYSTROPHY; DRUSEN; ELECTROOCULOGRAPHY; ELECTROPHYSIOLOGICAL PROCEDURES; FLUORESCENCE ANGIOGRAPHY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GEOGRAPHIC ATROPHY; HYPERPIGMENTATION; INDOCYANINE GREEN ANGIOGRAPHY; LATE ONSET CONE DYSTROPHY; LATE ONSET RETINAL DEGENERATION; MACULAR TELANGIECTASIA; MATERNALLY INHERITED DIABETES AND DEAFNESS; MELAS SYNDROME; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; METAMORPHOSIS; MYOTONIC DYSTROPHY; NONHUMAN; NORTH CAROLINA MACULAR DYSTROPHY; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; PIGMENT DISORDER; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA DETACHMENT; RETINA DYSTROPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RETINA MACULA VITELLIFORM DEGENERATION; RETINAL THICKNESS; RETINITIS PIGMENTOSA; REVIEW; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; STARGARDT DISEASE; SUBRETINAL NEOVASCULARIZATION; TELANGIECTASIA; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

AGE-RELATED MACULAR DEGENERATION; AMD; CLINICAL CHARACTERISTICS; DIFFERENTIAL DIAGNOSIS; MACULAR DYSTROPHY; RETINA;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MACULAR DEGENERATION; RETINAL DISEASES;

EID: 84893787933     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2013.11.001     Document Type: Review

References (330)

1. Agarwal A. Gass' Atlas of Macular Diseases 2012, Elsevier, Nashville. fifth ed.
2. Agarwal A., Patel P., Adkins T., Gass J.D. Spectrum of pattern dystrophy in pseudoxanthoma elasticum. Arch. Ophthalmol. 2005, 123:923-928.
3. Arandomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 2001, 119:1417-1436. Age-Related Eye Disease Study Research, G.
4. Alchi B., Jayne D. Membranoproliferative glomerulonephritis. Pediatr. Nephrol. 2010, 25:1409-1418.
5. Alkuraya H., Zhang K. Pattern dystrophy of the retinal pigment epithelium. Ret. Phys. 2010.
6. Allikmets R. Stargardt disease: from gene discovery to therapy. Retinal Degeneration: Biology, Diagnostics and Therapeutics 2007, 105-118. Humana Press, Totowa, NJ. J. Tombran-Tink, C.J. Barnstable (Eds.).
7. Allikmets R., Shroyer N.F., Singh N., Seddon J.M., Lewis R.A., Bernstein P.S., Peiffer A., Zabriskie N.A., Li Y., Hutchinson A., Dean M., Lupski J.R., Leppert M. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997, 277:1805-1807.
8. Anderson D.H., Ozaki S., Nealon M., Neitz J., Mullins R.F., Hageman G.S., Johnson L.V. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am. J. Ophthalmol. 2001, 131:767-781.
9. Appel G.B., Cook H.T., Hageman G., Jennette J.C., Kashgarian M., Kirschfink M., Lambris J.D., Lanning L., Lutz H.U., Meri S., Rose N.R., Salant D.J., Sethi S., Smith R.J., Smoyer W., Tully H.F., Tully S.P., Walker P., Welsh M., Wurzner R., Zipfel P.F. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J.Am. Soc. Nephrol. 2005, 16:1392-1403.
10. Arikawa K., Molday L.L., Molday R.S., Williams D.S. Localization of peripherin/rds in the disk membranes of cone and rod photoreceptors: relationship to disk membrane morphogenesis and retinal degeneration. J.Cell Biol. 1992, 116:659-667.
11. Armstrong J.D., Meyer D., Xu S., Elfervig J.L. Long-term follow-up of Stargardt's disease and fundus flavimaculatus. Ophthalmology 1998, 105:448-457. Discussion 457-448.
12. Arnold J.J., Sarks J.P., Killingsworth M.C., Kettle E.K., Sarks S.H. Adult vitelliform macular degeneration: a clinicopathological study. Eye (Lond) 2003, 17:717-726.
13. Ashton N. Central areolar choroidal sclerosis; a histo-pathological study. Br. J. Ophthalmol. 1953, 37:140-147.
14. Assink J.J., de Backer E., ten Brink J.B., Kohno T., de Jong P.T., Bergen A.A., Meire F. Sorsby fundus dystrophy without a mutation in the TIMP-3 gene. Br. J. Ophthalmol. 2000, 84:682-686.
15. Audo I., Vanakker O.M., Smith A., Leroy B.P., Robson A.G., Jenkins S.A., Coucke P.J., Bird A.C., De Paepe A., Holder G.E., Webster A.R. Pseudoxanthoma elasticum with generalized retinal dysfunction, a common finding?. Invest. Ophthalmol. Vis. Sci. 2007, 48:4250-4256.
16. Balaskas K., Hovan M., Mahmood S., Bishop P. Ranibizumab for the management of Sorsby fundus dystrophy. Eye (London, England) 2013, 27:101-102.
17. Barbazetto I.A., Room M., Yannuzzi N.A., Barile G.R., Merriam J.E., Bardal A.M., Freund K.B., Yannuzzi L.A., Allikmets R. ATM gene variants in patients with idiopathic perifoveal telangiectasia. Invest. Ophthalmol. Vis. Sci. 2008, 49:3806-3811.
18. Batten F., Gibb H. Myotonia atrophica. Brain 1909, 32:187-205.
19. Baumuller S., Charbel Issa P., Scholl H.P., Schmitz-Valckenberg S., Holz F.G. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2. Ophthalmology 2010, 117:2162-2168.
20. Bellmann C., Neveu M.M., Scholl H.P., Hogg C.R., Rath P.P., Jenkins S., Bird A.C., Holder G.E. Localized retinal electrophysiological and fundus autofluorescence imaging abnormalities in maternal inherited diabetes and deafness. Invest. Ophthalmol. Vis. Sci. 2004, 45:2355-2360.
21. Berger S.P., Daha M.R. Complement in glomerular injury. Semin Immunopathol. 2007, 29:375-384.
22. Bindewald A., Schmitz-Valckenberg S., Jorzik J.J., Dolar-Szczasny J., Sieber H., Keilhauer C., Weinberger A.W., Dithmar S., Pauleikhoff D., Mansmann U., Wolf S., Holz F.G. Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration. Br. J. Ophthalmol. 2005, 89:874-878.
23. Bird A.C., Bressler N.M., Bressler S.B., Chisholm I.H., Coscas G., Davis M.D., de Jong P.T., Klaver C.C., Klein B.E., Klein R., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv. Ophthalmol. 1995, 39:367-374.
24. Boon C.J., Klevering B.J., den Hollander A.I., Zonneveld M.N., Theelen T., Cremers F.P., Hoyng C.B. Clinical and genetic heterogeneity in multifocal vitelliform dystrophy. Arch. Ophthalmol. 2007, 125:1100-1106.
25. Boon C.J., van Schooneveld M.J., den Hollander A.I., van Lith-Verhoeven J.J., Zonneveld-Vrieling M.N., Theelen T., Cremers F.P., Hoyng C.B., Klevering B.J. Mutations in the peripherin/RDS gene are an important cause of multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus. Br. J. Ophthalmol. 2007, 91:1504-1511.
26. Boon C.J., den Hollander A.I., Hoyng C.B., Cremers F.P., Klevering B.J., Keunen J.E. The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene. Prog. Ret. Eye Res. 2008, 27:213-235.
27. Boon C.J., Jeroen Klevering B., Keunen J.E., Hoyng C.B., Theelen T. Fundus autofluorescence imaging of retinal dystrophies. Vis. Res. 2008, 48:2569-2577.
28. Boon C.J., Klevering B.J., Hoyng C.B., Zonneveld-Vrieling M.N., Nabuurs S.B., Blokland E., Cremers F.P., den Hollander A.I. Basal laminar drusen caused by compound heterozygous variants in the CFH gene. Am. J. Hum. Genet. 2008, 82:516-523.
29. Boon C.J., Klevering B.J., Cremers F.P., Zonneveld-Vrieling M.N., Theelen T., Den Hollander A.I., Hoyng C.B. Central areolar choroidal dystrophy. Ophthalmology 2009, 116:771-782. 782 e771.
30. Boon C.J., Klevering B.J., Leroy B.P., Hoyng C.B., Keunen J.E., den Hollander A.I. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog. Ret. Eye Res. 2009, 28:187-205.
31. Boon C.J., Theelen T., Hoefsloot E.H., van Schooneveld M.J., Keunen J.E., Cremers F.P., Klevering B.J., Hoyng C.B. Clinical and molecular genetic analysis of best vitelliform macular dystrophy. Retina (Philadelphia, Pa.) 2009, 29:835-847.
32. Boon C.J., van de Kar N.C., Klevering B.J., Keunen J.E., Cremers F.P., Klaver C.C., Hoyng C.B., Daha M.R., den Hollander A.I. The spectrum of phenotypes caused by variants in the CFH gene. Mol. Immunol. 2009, 46:1573-1594.
33. Boon C.J., van den Born L.I., Visser L., Keunen J.E., Bergen A.A., Booij J.C., Riemslag F.C., Florijn R.J., van Schooneveld M.J. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options. Ophthalmology 2013, 120:809-820.
34. Borooah S., Collins C., Wright A., Dhillon B. Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration. Br. J. Ophthalmol. 2009, 93:284-289.
35. Boulton M. Ageing of the retina and retinal pigment epithelium. Age-related Macular Degeneration 2013, 45-63. Springer, Heidelberg, New York, Dordrecht, London. F.G. Holz, D. P., R.F. Spaide, A.C. Bird (Eds.).
36. Brecher R., Bird A.C. Adult vitelliform macular dystrophy. Eye (London, England) 1990, 4(1):210-215.
37. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 69:385.
38. Buitendijk G.H., Rochtchina E., Myers C., van Duijn C.M., Lee K.E., Klein B.E., Meuer S.M., de Jong P.T., Holliday E.G., Tan A.G., Uitterlinden A.G., Sivakumaran T.S., Attia J., Hofman A., Mitchell P., Vingerling J.R., Iyengar S.K., Janssens A.C., Wang J.J., Klein R., Klaver C.C. Prediction of age-related macular degeneration in the general population: the three Continent AMD Consortium. Ophthalmology 2013, (published online ahead of print).
39. Burian H.M., Burns C.A. Ocular changes in myotonic dystrophy. Am. J. Ophthalmol. 1967, 63:22-34.
40. Burke T.R., Tsang S.H. Allelic and phenotypic heterogeneity in ABCA4 mutations. Ophthal. Genetics 2011, 32:165-174.
41. Capon M.R., Polkinghorne P.J., Fitzke F.W., Bird A.C. Sorsby's pseudoinflammatory macula dystrophy-Sorsby's fundus dystrophies. Eye (London, England) 1988, 2(Pt 1):114-122.
42. Capon M.R., Marshall J., Krafft J.I., Alexander R.A., Hiscott P.S., Bird A.C. Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology 1989, 96:1769-1777.
43. Castro-Correia J., Coutinho M.F., Rosas V., Maia J. Long-term follow-up of central serous retinopathy in 150 patients. Documenta Ophthalmologica. Adv. Ophthalmol. 1992, 81:379-386.
44. Charbel Issa P., Berendschot T.T., Staurenghi G., Holz F.G., Scholl H.P. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest. Ophthalmol. Vis. Sci. 2008, 49:1172-1177.
45. Charbel Issa P., Finger R.P., Holz F.G., Scholl H.P. Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest. Ophthalmol. Vis. Sci. 2009, 50:5913-5918.
46. Chassaing N., Martin L., Calvas P., Le Bert M., Hovnanian A. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J.Med. Genet. 2005, 42:881-892.
47. Chavali V.R., Khan N.W., Cukras C.A., Bartsch D.U., Jablonski M.M., Ayyagari R. ACTRP5 gene S163R mutation knock-in mouse model for late-onset retinal degeneration. Hum. Mol. Genet. 2011, 20:2000-2014.
48. Chen H., Wu D., Huang S., Guan T., Liu C. Microperimetry evaluation in central serous chorioretinopathy. Yan Ke Xue Bao 2006, 22:149-153.
49. Cherepanoff, S., Killingsworth, M.C., Zhu, M., Nolan, T., Hunyor, A.P., Young, S.H., Hageman, G.S., Gillies, M.C., Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. Br. J. Ophthalmol. 96, 1404-1409.
50. Chinnery P.F., Howell N., Andrews R.M., Turnbull D.M. Clinical mitochondrial genetics. J.Med. Genet. 1999, 36:425-436.
51. Chung M.M., Oh K.T., Streb L.M., Kimura A.E., Stone E.M. Visual outcome following subretinal hemorrhage in Best disease. Retina (Philadelphia, Pa.) 2001, 21:575-580.
52. Clarkson J.G., Altman R.D. Angioid streaks. Surv. Ophthalmol. 1982, 26:235-246.
53. Clemett R. Vitelliform dystrophy: long-term observations on New Zealand pedigrees. Austr. N. Z. J. Ophthalmol. 1991, 19:221-227.
54. Collins E.T. Apathological report upon a case of Doyne's chorioditis ('Honeycomb'or 'family' choroiditis). Ophthalmocope 1913, 11:2.
55. Connell G., Bascom R., Molday L., Reid D., McInnes R.R., Molday R.S. Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:723-726.
56. Conner P.J., Juergens J.L. Pseudoxanthoma elasticum and angioid streaks. A review of 106 cases. Am. J. Med. 1961, 30:537-543.
57. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14682-14687.
58. Dandekar S.S., Jenkins S.A., Peto T., Scholl H.P., Sehmi K.S., Fitzke F.W., Bird A.C., Webster A.R. Autofluorescence imaging of choroidal neovascularization due to age-related macular degeneration. Arch. Ophthalmol. 2005, 123:1507-1513.
59. de Laat P., Koene S., van den Heuvel L.P., Rodenburg R.J., Janssen M.C., Smeitink J.A. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation. J.Inh. Metabol. Dis. 2012, 35:1059-1069.
60. de Laat P., Koene S., Heuvel L.P., Rodenburg R.J., Janssen M.C., Smeitink J.A. Inheritance of the m.3243A>G mutation. JIMD Rep. 2013, 8:47-50.
61. de Laat P., Smeitink J.A., Janssen M.C., Keunen J.E., Boon C.J. Mitochondrial retinal dystrophy associated with the m.3243A>G mutation. Ophthalmology 2013, (published online ahead of print).
62. Della N.G., Campochiaro P.A., Zack D.J. Localization of TIMP-3 mRNA expression to the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1996, 37:1921-1924.
63. Deutman A.F. Electro-oculography in families with vitelliform dystrophy of the fovea. Detection of the carrier state. Arch. Ophthalmol. 1969, 81:305-316.
64. Deutman A.F. Vitelliform Dystrophy of the Fovea. The Hereditary Dystrophies of the Posterior Pole of the Eye 1971, Van gorcum & Comp. N.V, Assen.
65. Deutman A.F., Jansen L.M. Dominantly inherited drusen of Bruch's membrane. Br. J. Ophthalmol. 1970, 54:373-382.
66. Deutman A.F., van Blommestein J.D., Henkes H.E., Waardenburg P.J., Solleveld-van Driest E. Butterfly-shaped pigment dystrophy of the fovea. Arch. Ophthalmol. 1970, 83:558-569.
67. Donoso L.A., Kim D., Frost A., Callahan A., Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2006, 51:137-152.
68. Doyne R. Peculiar condition of choroiditis occuring in several members of the same family. Trans. Ophthalmol. Soc. UK 1899, 19:71.
69. Dreyer R., Green W.R. The pathology of angioid streaks: a study of twenty-one cases. Trans. Pa Acad. Ophthalmol. Otolaryngol. 1978, 31:158-167.
70. Dubovy S.R., Hairston R.J., Schatz H., Schachat A.P., Bressler N.M., Finkelstein D., Green W.R. Adult-onset foveomacular pigment epithelial dystrophy: clinicopathologic correlation of three cases. Retina (Philadelphia, Pa.) 2000, 20:638-649.
71. Dusek J., Streicher T., Schmidt K. Hereditary drusen of Bruch's membrane. II: studies of semi-thin sections and electron microscopy results. Klin. Monbl. fur Augenheilkd. 1982, 181:79-83.
72. Duvall-Young J., MacDonald M.K., McKechnie N.M. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br. J. Ophthalmol. 1989, 73:297-302.
73. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
74. Evans K., Gregory C.Y., Wijesuriya S.D., Kermani S., Jay M.R., Plant C., Bird A.C. Assessment of the phenotypic range seen in Doyne honeycomb retinal dystrophy. Arch. Ophthalmol. 1997, 115:904-910.
75. Fariss R.N., Apte S.S., Luthert P.J., Bird A.C., Milam A.H. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br. J. Ophthalmol. 1998, 82:1329-1334.
76. Felbor U., Benkwitz C., Klein M.L., Greenberg J., Gregory C.Y., Weber B.H. Sorsby fundus dystrophy: reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation. Arch. Ophthalmol. 1997, 115:1569-1571.
77. Ferris F.L., Davis M.D., Clemons T.E., Lee L.Y., Chew E.Y., Lindblad A.S., Milton R.C., Bressler S.B., Klein R. Asimplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch. Ophthalmol. 2005, 123:1570-1574.
78. Ferris F.L., Wilkinson C.P., Bird A., Chakravarthy U., Chew E., Csaky K., Sadda S.R. Clinical classification of age-related macular degeneration. Ophthalmology 2013, 120:844-851.
79. Ferry A.P., Llovera I., Shafer D.M. Central areolar choroidal dystrophy. Arch. Ophthalmol. 1972, 88:39-43.
80. Finger R.P., Charbel Issa P., Ladewig M.S., Gotting C., Szliska C., Scholl H.P., Holz F.G. Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv. Ophthalmol. 2009, 54:272-285.
81. Fishman G.A., Birch D.G., Holder G.E., et al. Electrophysiologic Testing in Disorders of the Retina, Optic Nerve, and Visual Pathway, Ophthalmology Monograph 2001, Foundation of the American Academy of Ophthalmology, San Francisco. second ed.
82. Fleckenstein M., Charbel Issa P., Helb H.M., Schmitz-Valckenberg S., Finger R.P., Scholl H.P., Loeffler K.U., Holz F.G. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:4137-4144.
83. Fleckenstein M., Schmitz-Valckenberg S., Adrion C., Kramer I., Eter N., Helb H.M., Brinkmann C.K., Charbel Issa P., Mansmann U., Holz F.G. Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2010, 51:3846-3852.
84. Folgar F.A., Chow J.H., Farsiu S., Wong W.T., Schuman S.G., O'Connell R.V., Winter K.P., Chew E.Y., Hwang T.S., Srivastava S.K., Harrington M.W., Clemons T.E., Toth C.A. Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD. Invest. Ophthalmol. Vis. Sci. 2012, 53:4626-4633.
85. Framme C., Bunse A., Sofroni R., Thalhammer T., Walter A., Sachs H.G., Gabel V.P. Fundus autofluorescence before and after photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration. Ophthal. Surg. Lasers Imaging 2006, 37:406-414.
86. Francois J., de Rouck A. Electrophysiological studies in Groenblad-strandberg syndrome. Doc. Ophthalmol. Proc. Ser 1980, 23:19-25.
87. Francois J., de Rouck A., Verriest G., de Laey J.J., Cambie E. Progressive generalized cone dysfunction. Ophthalmologica 1974, 169:255-284.
88. Freund K.B., Laud K., Lima L.H., Spaide R.F., Zweifel S., Yannuzzi L.A. Acquired Vitelliform lesions: correlation of clinical findings and multiple imaging analyses. Retina (Philadelphia, Pa.) 2011, 31:13-25.
89. Friedman D.S., Katz J., Bressler N.M., Rahmani B., Tielsch J.M. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology 1999, 106:1049-1055.
90. Fritsche L.G., Chen W., Schu M., Yaspan B.L., Yu Y., Thorleifsson G., Zack D.J., Arakawa S., Cipriani V., Ripke S., Igo R.P., Buitendijk G.H., Sim X., Weeks D.E., Guymer R.H., Merriam J.E., Francis P.J., Hannum G., Agarwal A., Armbrecht A.M., Audo I., Aung T., Barile G.R., Benchaboune M., Bird A.C., Bishop P.N., Branham K.E., Brooks M., Brucker A.J., Cade W.H., Cain M.S., Campochiaro P.A., Chan C.C., Cheng C.Y., Chew E.Y., Chin K.A., Chowers I., Clayton D.G., Cojocaru R., Conley Y.P., Cornes B.K., Daly M.J., Dhillon B., Edwards A.O., Evangelou E., Fagerness J., Ferreyra H.A., Friedman J.S., Geirsdottir A., George R.J., Gieger C., Gupta N., Hagstrom S.A., Harding S.P., Haritoglou C., Heckenlively J.R., Holz F.G., Hughes G., Ioannidis J.P., Ishibashi T., Joseph P., Jun G., Kamatani Y., Katsanis N., Keilhauer N.C., Khan J.C., Kim I.K., Kiyohara Y., Klein B.E., Klein R., Kovach J.L., Kozak I., Lee C.J., Lee K.E., Lichtner P., Lotery A.J., Meitinger T., Mitchell P., Mohand-Said S., Moore A.T., Morgan D.J., Morrison M.A., Myers C.E., Naj A.C., Nakamura Y., Okada Y., Orlin A., Ortube M.C., Othman M.I., Pappas C., Park K.H., Pauer G.J., Peachey N.S., Poch O., Priya R.R., Reynolds R., Richardson A.J., Ripp R., Rudolph G., Ryu E., Sahel J.A., Schaumberg D.A., Scholl H.P., Schwartz S.G., Scott W.K., Shahid H., Sigurdsson H., Silvestri G., Sivakumaran T.A., Smith R.T., Sobrin L., Souied E.H., Stambolian D.E., Stefansson H., Sturgill-Short G.M., Takahashi A., Tosakulwong N., Truitt B.J., Tsironi E.E., Uitterlinden A.G., van Duijn C.M., Vijaya L., Vingerling J.R., Vithana E.N., Webster A.R., Wichmann H.E., Winkler T.W., Wong T.Y., Wright A.F., Zelenika D., Zhang M., Zhao L., Zhang K., Klein M.L., Hageman G.S., Lathrop G.M., Stefansson K., Allikmets R., Baird P.N., Gorin M.B., Wang J.J., Klaver C.C., Seddon J.M., Pericak-Vance M.A., Iyengar S.K., Yates J.R., Swaroop A., Weber B.H., Kubo M., Deangelis M.M., Leveillard T., Thorsteinsdottir U., Haines J.L., Farrer L.A., Heid I.M., Abecasis G.R., Consortium A.M.D.G. Seven new loci associated with age-related macular degeneration. Nat. Genet. 2013, 45:433-439. 439e431-432.
91. Fu L., Garland D., Yang Z., Shukla D., Rajendran A., Pearson E., Stone E.M., Zhang K., Pierce E.A. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum. Mol. Genet. 2007, 16:2411-2422.
92. Gass J.D. Aclinicopathologic study of a peculiar foveomacular dystrophy. Trans. Am. Ophthalmol. Soc. 1974, 72:139-156.
93. Gass J.D. "Comet" lesion: an ocular sign of pseudoxanthoma elasticum. Retina 2003, 23:729-730.
94. Gass J.D., Blodi B.A. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993, 100:1536-1546.
95. Gass J.D., Oyakawa R.T. Idiopathic juxtafoveolar retinal telangiectasis. Arch. Ophthalmol. 1982, 100:769-780.
96. Georgalas I., Papaconstantinou D., Koutsandrea C., Kalantzis G., Karagiannis D., Georgopoulos G., Ladas I. Angioid streaks, clinical course, complications, and current therapeutic management. Ther. Clin. Risk Manag. 2009, 5:81-89.
97. Gerber D.M., Niemeyer G. Ganzfeld and multifocal electroretinography in malattia leventinese and Zermatt macular dystrophy. Klin. Monbl. Augenheilkd. 2002, 219:206-210.
98. Gilbert C.M., Owens S.L., Smith P.D., Fine S.L. Long-term follow-up of central serous chorioretinopathy. Br. J. Ophthalmol. 1984, 68:815-820.
99. Gillies M.C., Zhu M., Chew E., Barthelmes D., Hughes E., Ali H., Holz F.G., Scholl H.P., Charbel Issa P. Familial asymptomatic macular telangiectasia type 2. Ophthalmology 2009, 116:2422-2429.
100. Giovannini A., Scassellati-Sforzolini B., D'Altobrando E., Mariotti C., Rutili T., Tittarelli R. Choroidal findings in the course of idiopathic serous pigment epithelium detachment detected by indocyanine green videoangiography. Retina (Philadelphia, Pa.) 1997, 17:286-293.
101. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R., Smith R.T., Hageman G.S., Dean M., Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 2006, 38:458-462.
102. Gomes-Pereira M., Cooper T.A., Gourdon G. Myotonic dystrophy mouse models: towards rational therapy development. Trends Mol. Med. 2011, 17:506-517.
103. Goto Y., Nonaka I., Horai S. Amutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 348:651-653.
104. Green W.R., Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993, 100:1519-1535.
105. Green W.R., Key S.N. Senile macular degeneration: a histopathologic study. Trans. Am. Ophthalmol. Soc. 1977, 75:180-254.
106. Groenblad E. Color photographs of angioid streaks in the late stages. Acta. Ophthalmol. 1958, 36:472-474.
107. Grossniklaus H.E., Miskala P.H., Green W.R., Bressler S.B., Hawkins B.S., Toth C., Wilson D.J., Bressler N.M. Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7. Arch. Ophthalmol. 2005, 123:914-921.
108. Guigui B., Leveziel N., Martinet V., Massamba N., Sterkers M., Coscas G., Souied E.H. Angiography features of early onset drusen. Br. J. Ophthalmol. 2011, 95:238-244.
109. Gundogan F.C., Dinc U.A., Erdem U., Ozge G., Sobaci G. Multifocal electroretinogram and central visual field testing in central areolar choroidal dystrophy. Eur. J. Ophthalmol. 2010, 20:919-924.
110. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin Eye Res. 2001, 20:705-732.
111. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., Allikmets R. Acommon haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7227-7232.
112. Haimovici R., Wroblewski J., Piguet B., Fitzke F.W., Holder G.E., Arden G.B., Bird A.C. Symptomatic abnormalities of dark adaptation in patients with EFEMP1 retinal dystrophy (Malattia Leventinese/Doyne honeycomb retinal dystrophy). Eye (Lond) 2002, 16:7-15.
113. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
114. Hamilton W.K., Ewing C.C., Ives E.J., Carruthers J.D. Sorsby's fundus dystrophy. Ophthalmology 1989, 96:1755-1762.
115. Hannan S.R., de Salvo G., Stinghe A., Shawkat F., Lotery A.J. Common spectral domain OCT and electrophysiological findings in different pattern dystrophies. Br. J. Ophthalmol. 2013, 97:605-610.
116. Harper P.S. Myotonic Dystrophy 2001, Saunders, London.
117. Hayward C., Shu X., Cideciyan A.V., Lennon A., Barran P., Zareparsi S., Sawyer L., Hendry G., Dhillon B., Milam A.H., Luthert P.J., Swaroop A., Hastie N.D., Jacobson S.G., Wright A.F. Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration. Hum. Mol. Genet. 2003, 12:2657-2667.
118. Helb H.M., Charbel Issa P., RL V.D.V., Berendschot T.T., Scholl H.P., Holz F.G. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina 2008, 28:808-816.
119. Ho J., Witkin A.J., Liu J., Chen Y., Fujimoto J.G., Schuman J.S., Duker J.S. Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2011, 118:687-693.
120. Holz F.G., Bellman C., Staudt S., Schutt F., Volcker H.E. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2001, 42:1051-1056.
121. Holz F.G., Bindewald-Wittich A., Fleckenstein M., Dreyhaupt J., Scholl H.P., Schmitz-Valckenberg S. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am. J. Ophthalmol. 2007, 143:463-472.
122. Hoskin A., Sehmi K., Bird A.C. Sorsby's pseudoinflammatory macular dystrophy. Br. J. Ophthalmol. 1981, 65:859-865.
123. Hoyng C.B., Deutman A.F. The development of central areolar choroidal dystrophy. Graefe's Arch. Clin. Exp. Ophthalmol. 1996, 234:87-93.
124. Hu X., Plomp A.S., van Soest S., Wijnholds J., de Jong P.T., Bergen A.A. Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv. Ophthalmol. 2003, 48:424-438.
125. Inhoffen W., Ziemssen F., Bartz-Schmidt K.U. Chronic central serous chorioretinopathy (cCSC): differential diagnosis to choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD). Klin. Monbl. Augenheilkd. 2012, 229:889-896.
126. Isashiki Y., Tabata Y., Kamimura K., Ohba N. Sorsby's fundus dystrophy in two Japanese families with unusual clinical features. Jap. J. Ophthalmol. 1999, 43:472-480.
127. Issa P.C., Helb H.M., Rohrschneider K., Holz F.G., Scholl H.P. Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia. Invest. Ophthalmol. Vis. Sci. 2007, 48:3788-3795.
128. Issa P.C., Gillies M.C., Chew E.Y., Bird A.C., Heeren T.F., Peto T., Holz F.G., Scholl H.P. Macular telangiectasia type 2. Prog. Retin. Eye Res. 2013, 34:49-77.
129. Jaakson K., Zernant J., Kulm M., Hutchinson A., Tonisson N., Glavac D., Ravnik-Glavac M., Hawlina M., Meltzer M.R., Caruso R.C., Testa F., Maugeri A., Hoyng C.B., Gouras P., Simonelli F., Lewis R.A., Lupski J.R., Cremers F.P., Allikmets R. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum. Mut. 2003, 22:395-403.
130. Jackson G.R., Owsley C., McGwin G. Aging and dark adaptation. Vis. Res. 1999, 39:3975-3982.
131. Jakobsdottir J., Conley Y.P., Weeks D.E., Mah T.S., Ferrell R.E., Gorin M.B. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am. J. Hum. Genet. 2005, 77:389-407.
132. Jaouni T., Averbukh E., Burstyn-Cohen T., Grunin M., Banin E., Sharon D., Chowers I. Association of pattern dystrophy with an HTRA1 single-nucleotide polymorphism. Arch. Ophthalmol. 2012, 130:987-991.
133. Kawasaki R., Yasuda M., Song S.J., Chen S.J., Jonas J.B., Wang J.J., Mitchell P., Wong T.Y. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 2010, 117:921-927.
134. Kellner U., Kellner S. Clinical findings and diagnostics of cone dystrophy. Ophthalmologe 2009, 106:99-108.
135. Khanifar A.A., Koreishi A.F., Izatt J.A., Toth C.A. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology 2008, 115:1883-1890.
136. Khurana R.N., Sun X., Pearson E., Yang Z., Harmon J., Goldberg M.F., Zhang K. Areappraisal of the clinical spectrum of North Carolina macular dystrophy. Ophthalmology 2009, 116:1976-1983.
137. Kiernan D.F., Shah R.J., Hariprasad S.M., Grassi M.A., Small K.W., Kiernan J.P., Mieler W.F. Thirty-Year follow-up of an African American family with macular dystrophy of the retina, locus 1 (North Carolina macular dystrophy). Ophthalmology 2011, 118:1435-1443.
138. Kim R.Y., Dollfus H., Keen T.J., Fitzke F.W., Arden G.B., Bhattacharya S.S., Bird A.C. Autosomal dominant pattern dystrophy of the retina associated with a 4-base pair insertion at codon 140 in the peripherin/RDS gene. Arch. Ophthalmol. 1995, 113:451-455.
139. Kim R.Y., Faktorovich E.G., Kuo C.Y., Olson J.L. Retinal function abnormalities in membranoproliferative glomerulonephritis type II. Am. J. Ophthalmol. 1997, 123:619-628.
140. Kim U.S., Kim J.S., Hwang J.M. Acase of myotonic dystrophy with pigmentary retinal changes. Kor. J. Ophthalmol. 2009, 23:121-123.
141. Kimizuka Y., Kiyosawa M., Tamai M., Takase S. Retinal changes in myotonic dystrophy. Clinical and follow-up evaluation. Retina 1993, 13:129-135.
142. Klein B.A. Angioid streaks: a clinical and histopathologic study. Am. J. Ophthalmol. 1947, 30:955-968.
143. Klein R., Davis M.D., Magli Y.L., Segal P., Klein B.E., Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991, 98:1128-1134.
144. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
145. Klein R., Klein B.E., Knudtson M.D., Meuer S.M., Swift M., Gangnon R.E. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007, 114:253-262.
146. Klein R., Meuer S.M., Knudtson M.D., Iyengar S.K., Klein B.E. The epidemiology of retinal reticular drusen. Am. J. Ophthalmol. 2008, 145:317-326.
147. Klevering B.J., van Driel M., van Hogerwou A.J., van De Pol D.J., Deutman A.F., Pinckers A.J., Cremers F.P., Hoyng C.B. Central areolar choroidal dystrophy associated with dominantly inherited drusen. Br. J. Ophthalmol. 2002, 86:91-96.
148. Klevering B.J., Deutman A.F., Maugeri A., Cremers F.P., Hoyng C.B. The spectrum of retinal phenotypes caused by mutations in the ABCA4 gene. Graefe's Arch. Clin. Exp. Ophthalmol. 2005, 243:90-100.
149. Knudtson M.D., Klein R., Klein B.E., Lee K.E., Meuer S.M., Tomany S.C. Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study. Invest. Ophthalmol. Vis. Sci. 2004, 45:2135-2142.
150. Kobayashi Y., Momoi M.Y., Tominaga K., Momoi T., Nihei K., Yanagisawa M., Kagawa Y., Ohta S. Apoint mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem. Biophys. Res. Commun. 1990, 173:816-822.
151. Koopman W.J., Willems P.H., Smeitink J.A. Monogenic mitochondrial disorders. N.Engl. J. Med. 2012, 366:1132-1141.
152. Kramer F., White K., Pauleikhoff D., Gehrig A., Passmore L., Rivera A., Rudolph G., Kellner U., Andrassi M., Lorenz B., Rohrschneider K., Blankenagel A., Jurklies B., Schilling H., Schutt F., Holz F.G., Weber B.H. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur. J. Hum. Genet. 2000, 8:286-292.
153. Krill A.E., Deutman A.F., Fishman M. The cone degenerations. Doc. Ophthalmol. 1973, 35:1-80.
154. Krill A.E., Klien B.A., Archer D.B. Precursors of angioid streaks. Am. J. Ophthalmol. 1973, 76:875-879.
155. Kuntz C.A., Jacobson S.G., Cideciyan A.V., Li Z.Y., Stone E.M., Possin D., Milam A.H. Sub-retinal pigment epithelial deposits in a dominant late-onset retinal degeneration. Invest. Ophthalmol. Vis. Sci. 1996, 37:1772-1782.
156. Ladewig M., Kraus H., Foerster M.H., Kellner U. Cone dysfunction in patients with late-onset cone dystrophy and age-related macular degeneration. Arch. Ophthalmol. 2003, 121:1557-1561.
157. Lafaut B.A., Leys A.M., Scassellati-Sforzolini B., Priem H., De Laey J.J. Comparison of fluorescein and indocyanine green angiography in angioid streaks. Graefes Arch. Clin. Exp. Ophthalmol. 1998, 236:346-353.
158. Lam L.A. Angioid streaks. Retina 2013, 1267-1273. Elsevier, London, New York, Oxford, St. Louis, Sydney, Toronto. J.R. Ryan (Ed.).
159. Langton K.P., McKie N., Curtis A., Goodship J.A., Bond P.M., Barker M.D., Clarke M. Anovel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy. J.Biol. Chem. 2000, 275:27027-27031.
160. Langton K.P., McKie N., Smith B.M., Brown N.J., Barker M.D. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells. Hum. Mol. Genet. 2005, 14:3579-3586.
161. Langwinska-Wosko E., Szulborski K., Broniek-Kowalik K. Late onset cone dystrophy. Doc. Ophthalmol. 2010, 120:215-218.
162. Lefler W.H., Wadsworth J.A., Sidbury J.B. Hereditary macular degeneration and amino-aciduria. Am. J. Ophthalmol. 1971, 71:224-230.
163. Lengyel I., Flinn J.M., Peto T., Linkous D.H., Cano K., Bird A.C., Lanzirotti A., Frederickson C.J., van Kuijk F.J. High concentration of zinc in sub-retinal pigment epithelial deposits. Exp. Eye Res. 2007, 84:772-780.
164. Leu J., Schrage N.F., Degenring R.F. Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab. Graefe's Arch. Clin. Exp. Ophthalmol. 2007, 245:1723-1725.
165. Leys A., Proesmans W., Van Damme-Lombaerts R., Van Damme B. Specific eye fundus lesions in type II membranoproliferative glomerulonephritis. Pediatr. Nephrol. 1991, 5:189-192.
166. Leys A., Vanrenterghem Y., Van Damme B., Snyers B., Pirson Y., Leys M. Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefes Arch. Clin. Exp. Ophthalmol. 1991, 229:406-410.
167. Li C.M., Chung B.H., Presley J.B., Malek G., Zhang X., Dashti N., Li L., Chen J., Bradley K., Kruth H.S., Curcio C.A. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest. Ophthalmol. Vis. Sci. 2005, 46:2576-2586.
168. Lim L.S., Mitchell P., Seddon J.M., Holz F.G., Wong T.Y. Age-related macular degeneration. Lancet 2012, 379:1728-1738.
169. Lin R.J., Blumenkranz M.S., Binkley J., Wu K., Vollrath D. Anovel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy. Am. J. Ophthalmol. 2006, 142:839-848.
170. Lip P.L., Good P.A., Gibson J.M. Sorsby's fundus dystrophy: a case report of 24 years follow-up with electrodiagnostic tests and indocyanine green angiography. Eye (London, England) 1999, 13(1):16-25.
171. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., Day J.W., Ranum L.P. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
172. Lueck J.D., Lungu C., Mankodi A., Osborne R.J., Welle S.L., Dirksen R.T., Thornton C.A. Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am. J. Physiol. Cell Physiol. 2007, 292:C1291-C1297.
173. Malek G., Li C.M., Guidry C., Medeiros N.E., Curcio C.A. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am. J. Pathol. 2003, 162:413-425.
174. Maller J.B., Fagerness J.A., Reynolds R.C., Neale B.M., Daly M.J., Seddon J.M. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet. 2007, 39:1200-1201.
175. Manouvrier S., Rotig A., Hannebique G., Gheerbrandt J.D., Royer-Legrain G., Munnich A., Parent M., Grunfeld J.P., Largilliere C., Lombes A., et al. Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness. J.Med. Genet. 1995, 32:654-656.
176. Mansour A.M., Ansari N.H., Shields J.A., Annesley W.H., Cronin C.M., Stock E.L. Evolution of angioid streaks. Ophthalmologica 1993, 207:57-61.
177. Marano F., Deutman A.F., Leys A., Aandekerk A.L. Hereditary retinal dystrophies and choroidal neovascularization. Graefe's Arch. Clin. Exp. Ophthalmol. 2000, 238:760-764.
178. Marmorstein L. Association of EFEMP1 with malattia leventinese and age-related macular degeneration: a mini-review. Ophthal. Genet. 2004, 25:219-226.
179. Marmorstein L.Y., Munier F.L., Arsenijevic Y., Schorderet D.F., McLaughlin P.J., Chung D., Traboulsi E., Marmorstein A.D. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13067-13072.
180. Marmorstein L.Y., McLaughlin P.J., Peachey N.S., Sasaki T., Marmorstein A.D. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. Hum. Mol. Genet. 2007, 16:2423-2432.
181. Massin P., Virally-Monod M., Vialettes B., Paques M., Gin H., Porokhov B., Caillat-Zucman S., Froguel P., Paquis-Fluckinger V., Gaudric A., Guillausseau P.J. Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness. GEDIAM Group. Ophthalmology 1999, 106:1821-1827.
182. Mata N.L., Tzekov R.T., Liu X., Weng J., Birch D.G., Travis G.H. Delayed dark-adaptation and lipofuscin accumulation in abcr ± mice: implications for involvement of ABCR in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2001, 42:1685-1690.
183. Maugeri A., van Driel M.A., van de Pol D.J., Klevering B.J., van Haren F.J., Tijmes N., Bergen A.A., Rohrschneider K., Blankenagel A., Pinckers A.J., Dahl N., Brunner H.G., Deutman A.F., Hoyng C.B., Cremers F.P. The 2588G-->C mutation in the ABCR gene is a mild frequent founder mutation in the Western European population and allows the classification of ABCR mutations in patients with Stargardt disease. Am. J. Hum. Genet. 1999, 64:1024-1035.
184. Mauschitz M.M., Fonseca S., Chang P., Gobel A.P., Fleckenstein M., Jaffe G.J., Holz F.G., Schmitz-Valckenberg S. Topography of geographic atrophy in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2012, 53:4932-4939.
185. McAvoy C.E., Silvestri G. Retinal changes associated with type 2 glomerulonephritis. Eye (Lond) 2005, 19:985-989.
186. McBain V.A., Townend J., Lois N. Fundus autofluorescence in exudative age-related macular degeneration. Br. J. Ophthalmol. 2007, 91:491-496.
187. McBain V.A., Kumari R., Townend J., Lois N. Geographic atrophy in retinal angiomatous proliferation. Retina 2011, 31:1043-1052.
188. McBain V.A., Townend J., Lois N. Progression of retinal pigment epithelial atrophy in stargardt disease. Am. J. Ophthalmol. 2012, 154:146-154.
189. Meyerle C.B., Smith R.T., Barbazetto I.A., Yannuzzi L.A. Autofluorescence of basal laminar drusen. Retina 2007, 27:1101-1106.
190. Michaelides M., Johnson S., Tekriwal A.K., Holder G.E., Bellmann C., Kinning E., Woodruff G., Trembath R.C., Hunt D.M., Moore A.T. An early-onset autosomal dominant macular dystrophy (MCDR3) resembling North Carolina macular dystrophy maps to chromosome 5. Invest. Ophthalmol. Vis. Sci. 2003, 44:2178-2183.
191. Michaelides M., Holder G.E., Bradshaw K., Hunt D.M., Moore A.T. Cone-rod dystrophy, intrafamilial variability, and incomplete penetrance associated with the R172W mutation in the peripherin/RDS gene. Ophthalmology 2005, 112:1592-1598.
192. Michaelides M., Jenkins S.A., Brantley M.A., Andrews R.M., Waseem N., Luong V., Gregory-Evans K., Bhattacharya S.S., Fitzke F.W., Webster A.R. Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction. Invest. Ophthalmol. Vis. Sci. 2006, 47:3085-3097.
193. Michaelides M., Jenkins S.A., Bamiou D.E., Sweeney M.G., Davis M.B., Luxon L., Bird A.C., Rath P.P. Macular dystrophy associated with the A3243G mitochondrial DNA mutation. Distinct retinal and associated features, disease variability, and characterization of asymptomatic family members. Arch. Ophthalmol. 2008, 126:320-328.
194. Milam A.H., Curcio C.A., Cideciyan A.V., Saxena S., John S.K., Kruth H.S., Malek G., Heckenlively J.R., Weleber R.G., Jacobson S.G. Dominant late-onset retinal degeneration with regional variation of sub-retinal pigment epithelium deposits, retinal function, and photoreceptor degeneration. Ophthalmology 2000, 107:2256-2266.
195. Mimoun G., Soubrane G., Coscas G. Macular drusen. J.Fr. Ophtalmol. 1990, 13:511-530.
196. Mimoun G., Caillaux V., Querques G., Rothschild P.R., Puche N., Souied E.H. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results. Retina (Philadelphia, Pa.) 2013, 33:513-521.
197. Mohler C.W., Fine S.L. Long-term evaluation of patients with Best's vitelliform dystrophy. Ophthalmology 1981, 88:688-692.
198. Mullins R.F., Hageman G.S. Human ocular drusen possess novel core domains with a distinct carbohydrate composition. J.Histochem. Cytochem. 1999, 47:1533-1540.
199. Mullins R.F., Russell S.R., Anderson D.H., Hageman G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. Faseb J. 2000, 14:835-846.
200. Mullins R.F., Aptsiauri N., Hageman G.S. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye (Lond) 2001, 15:390-395.
201. Nakazawa M., Wada Y., Tamai M. Macular dystrophy associated with monogenic Arg172Trp mutation of the peripherin/RDS gene in a Japanese family. Retina (Philadelphia, Pa.) 1995, 15:518-523.
202. Neelam K., Nolan J., Chakravarthy U., Beatty S. Psychophysical function in age-related maculopathy. Surv. Ophthalmol. 2009, 54:167-210.
203. Nicholson B., Noble J., Forooghian F., Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv. Ophthalmol. 2013, 58:103-126.
204. O'Brien C., Duvall-Young J., Brown M., Short C., Bone M. Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities. Br. J. Ophthalmol. 1993, 77:778-780.
205. Oosterhuis J.A. Familial central serous retinopathy. Graefe's Arch. Clin. Exp. Ophthalmol. 1996, 234:337-341.
206. Palczewska G., Maeda T., Imanishi Y., Sun W., Chen Y., Williams D.R., Piston D.W., Maeda A., Palczewski K. Noninvasive multiphoton fluorescence microscopy resolves retinol and retinal condensation products in mouse eyes. Nat. Med. 2010, 16:1444-1449.
207. Parmalee N.L., Schubert C., Figueroa M., Bird A.C., Peto T., Gillies M.C., Bernstein P.S., Kiryluk K., Terwilliger J.D., Allikmets R., MacTel P. Identification of a potential susceptibility locus for macular telangiectasia type 2. Plos One 2012, 7:e24268.
208. Patrinely J.R., Lewis R.A., Font R.L. Foveomacular vitelliform dystrophy, adult type. A clinicopathologic study including electron microscopic observations. Ophthalmology 1985, 92:1712-1718.
209. Pawlak D., Souied E., Mimoun G., Papp-Pawlak M., Coscas G., Soubrane G. Fundus flavimaculatus and choroidal neovascularization. J.Fr. Ophtalmol. 2006, 29:188-194.
210. Pece A., Avanza P., Introini U., Brancato R. Indocyanine green angiography in angioid streaks. Acta Ophthalmol. Scand. 1997, 75:261-265.
211. Peters A.L., Young M.J., Miller J.K. Optical coherence tomography for assessing disease progression in sorsby fundus dystrophy. Retina (Philadelphia, Pa.) 2006, 26:1082-1084.
212. Petrukhin K., Koisti M.J., Bakall B., Li W., Xie G., Marknell T., Sandgren O., Forsman K., Holmgren G., Andreasson S., Vujic M., Bergen A.A., McGarty-Dugan V., Figueroa D., Austin C.P., Metzker M.L., Caskey C.T., Wadelius C. Identification of the gene responsible for Best macular dystrophy. Nat. Gen. 1998, 19:241-247.
213. Piguet B., Haimovici R., Bird A.C. Dominantly inherited drusen represent more than one disorder: a historical review. Eye (Lond) 1995, 9(Pt 1):34-41.
214. Piguet B., Heon E., Munier F.L., Grounauer P.A., Niemeyer G., Butler N., Schorderet D.F., Sheffield V.C., Stone E.M. Full characterization of the maculopathy associated with an Arg-172-Trp mutation in the RDS/peripherin gene. Ophthal. Genet. 1996, 17:175-186.
215. Polkinghorne P.J., Capon M.R., Berninger T., Lyness A.L., Sehmi K., Bird A.C. Sorsby's fundus dystrophy. A clinical study. Ophthalmology 1989, 96:1763-1768.
216. Powner M.B., Gillies M.C., Tretiach M., Scott A., Guymer R.H., Hageman G.S., Fruttiger M. Perifoveal muller cell depletion in a case of macular telangiectasia type 2. Ophthalmology 2010, 117:2407-2416.
217. Powner M.B., Gillies M.C., Zhu M., Vevis K., Hunyor A.P., Fruttiger M. Loss of Muller's cells and photoreceptors in macular telangiectasia type 2. Ophthalmology 2013, (Epub ahead of print).
218. Puche N., Querques G., Benhamou N., Tick S., Mimoun G., Martinelli D., Soubrane G., Souied E.H. High-resolution spectral domain optical coherence tomography features in adult onset foveomacular vitelliform dystrophy. Br. J. Ophthalmol. 2010, 94:1190-1196.
219. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., Baker A., Anand-Apte B. Anovel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 2003, 9:407-415.
220. Quaranta M., Cohen S.Y., Krott R., Sterkers M., Soubrane G., Coscas G.J. Indocyanine green videoangiography of angioid streaks. Am. J. Ophthalmol. 1995, 119:136-142.
221. Quazi F., Lenevich S., Molday R.S. ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine importer. Nat. Commun. 2012, 3:925.
222. Querques G., Regenbogen M., Quijano C., Delphin N., Soubrane G., Souied E.H. High-definition optical coherence tomography features in vitelliform macular dystrophy. Am. J. Ophthalmol. 2008, 146:501-507.
223. Querques G., Forte R., Querques L., Massamba N., Souied E.H. Natural course of adult-onset foveomacular vitelliform dystrophy: a spectral-domain optical coherence tomography analysis. Am. J. Ophthalmol. 2011, 152:304-313.
224. Querques G., Guigui B., Leveziel N., Querques L., Coscas G., Soubrane G., Souied E.H. Insights into pathology of cuticular drusen from integrated confocal scanning laser ophthalmoscopy imaging and corresponding spectral domain optical coherence tomography. Graefes Arch. Clin. Exp. Ophthalmol. 2011, 249:1617-1625.
225. Querques G., Guigui B., Leveziel N., Querques L., Bandello F., Souied E.H. Multimodal morphological and functional characterization of Malattia Leventinese. Graefes Arch. Clin. Exp. Ophthalmol. 2012, 251:705-714.
226. Radu R.A., Mata N.L., Bagla A., Travis G.H. Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:5928-5933.
227. Radu R.A., Yuan Q., Hu J., Peng J.H., Lloyd M., Nusinowitz S., Bok D., Travis G.H. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation. Invest. Ophthalmol. Vis. Sci. 2008, 49:3821-3829.
228. Radu R.A., Hu J., Yuan Q., Welch D.L., Makshanoff J., Lloyd M., McMullen S., Travis G.H., Bok D. Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration. J.Biol. Chem. 2011, 286:18593-18601.
229. Ranum L.P., Cooper T.A. RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci. 2006, 29:259-277.
230. Ranum L.P., Day J.W. Myotonic dystrophy: RNA pathogenesis comes into focus. Am. J. Hum. Genet. 2004, 74:793-804.
231. Rath P.P., Jenkins S., Michaelides M., Smith A., Sweeney M.G., Davis M.B., Fitzke F.W., Bird A.C. Characterisation of the macular dystrophy in patients with the A3243G mitochondrial DNA point mutation with fundus autofluorescence. Br. J. Ophthalmol. 2008, 92:623-629.
232. Raychaudhuri S., Iartchouk O., Chin K., Tan P.L., Tai A.K., Ripke S., Gowrisankar S., Vemuri S., Montgomery K., Yu Y., Reynolds R., Zack D.J., Campochiaro B., Campochiaro P., Katsanis N., Daly M.J., Seddon J.M. Arare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat. Genet. 2011, 43:1232-1236.
233. Reardon W., Ross R.J., Sweeney M.G., Luxon L.M., Pembrey M.E., Harding A.E., Trembath R.C. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992, 340:1376-1379.
234. Reichel M.B., Kelsell R.E., Fan J., Gregory C.Y., Evans K., Moore A.T., Hunt D.M., Fitzke F.W., Bird A.C. Phenotype of a British North Carolina macular dystrophy family linked to chromosome 6q. Br. J. Ophthalmol. 1998, 82:1162-1168.
235. Renner A.B., Tillack H., Kraus H., Kohl S., Wissinger B., Mohr N., Weber B.H., Kellner U., Foerster M.H. Morphology and functional characteristics in adult vitelliform macular dystrophy. Retina 2004, 24:929-939.
236. Renner A.B., Fiebig B.S., Weber B.H., Wissinger B., Andreasson S., Gal A., Cropp E., Kohl S., Kellner U. Phenotypic variability and long-term follow-up of patients with known and novel PRPH2/RDS gene mutations. Am. J. Ophthalmol. 2009, 147:518-530. e511.
237. Reynolds R., Hartnett M.E., Atkinson J.P., Giclas P.C., Rosner B., Seddon J.M. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest. Ophthalmol. Vis. Sci. 2009, 50:5818-5827.
238. Ringpfeil F., Pulkkinen L., Uitto J. Molecular genetics of pseudoxanthoma elasticum. Exp. Dermatol. 2001, 10:221-228.
239. Rivera A., Fisher S.A., Fritsche L.G., Keilhauer C.N., Lichtner P., Meitinger T., Weber B.H. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum. Mol. Genet. 2005, 14:3227-3236.
240. Ronan S., Nusinowitz S., Swaroop A., Heckenlively J.R. Senile panretinal cone dysfunction in age-related macular degeneration (AMD): a report of 52 amd patients compared to age-matched controls. Trans. Am. Ophthalmol. Soc. 2006, 104:232-240.
241. Rosenberg T., Roos B., Johnsen T., Bech N., Scheetz T.E., Larsen M., Stone E.M., Fingert J.H. Clinical and genetic characterization of a Danish family with North Carolina macular dystrophy. Mol. Vis. 2010, 16:2659-2668.
242. Rowe S.E., Trobe J.D., Sieving P.A. Idiopathic photoreceptor dysfunction causes unexplained visual acuity loss in later adulthood. Ophthalmology 1990, 97:1632-1637.
243. Rudnicka A.R., Jarrar Z., Wormald R., Cook D.G., Fletcher A., Owen C.G. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 2012, 119:571-580.
244. Saihan Z., Li Z., Rice J., Rana N.A., Ramsden S., Schlottmann P.G., Jenkins S.A., Blyth C., Black G.C., McKie N., Webster A.R. Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy. Mol. Vis. 2009, 15:1218-1230.
245. Sallo F.B., Leung I., Chung M., Wolf-Schnurrbusch U.E., Dubra A., Williams D.R., Clemons T., Pauleikhoff D., Bird A.C., Peto T. Retinal crystals in type 2 idiopathic macular telangiectasia. Ophthalmology 2011, 118:2461-2467.
246. Sarks S.H. Council Lecture. Drusen and their relationship to senile macular degeneration. Aust. J. Ophthalmol. 1980, 8:117-130.
247. Sarks J.P., Sarks S.H., Killingsworth M.C. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) 1988, 2(5):552-577.
248. Sarks J.P., Sarks S.H., Killingsworth M.C. Evolution of soft drusen in age-related macular degeneration. Eye (Lond) 1994, 8(Pt 3):269-283.
249. Sawa M., Ober M.D., Freund K.B., Spaide R.F. Fundus autofluorescence in patients with pseudoxanthoma elasticum. Ophthalmology 2006, 113:814-820. e812.
250. Schara U., Schoser B.G. Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin. Pediatr. Neurol. 2006, 13:71-79.
251. Schmitz-Valckenberg S., Fleckenstein M., Scholl H.P., Holz F.G. Fundus autofluorescence and progression of age-related macular degeneration. Surv. Ophthalmol. 2009, 54:96-117.
252. Schmitz-Valckenberg S., Ong E.E., Rubin G.S., Peto T., Tufail A., Egan C.A., Bird A.C., Fitzke F.W. Structural and functional changes over time in MacTel patients. Retina 2009, 29:1314-1320.
253. Schmitz-Valckenberg S., Steinberg J.S., Fleckenstein M., Visvalingam S., Brinkmann C.K., Holz F.G. Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology 2010, 117:1169-1176.
254. Schoenberger S.D., Agarwal A. Anovel mutation at the N-Terminal domain of the Timp3 gene in sorsby fundus dystrophy. Retina (Philadelphia, Pa.) 2013, 33:429-435.
255. Scholl H.P., Charbel Issa P., Walier M., Janzer S., Pollok-Kopp B., Borncke F., Fritsche L.G., Chong N.V., Fimmers R., Wienker T., Holz F.G., Weber B.H., Oppermann M. Systemic complement activation in age-related macular degeneration. PLoS One 2008, 3:e2593.
256. Schworm H.D., Ulbig M.W., Hoops J., Rudolph G., Weber B.H., Ehrt O., Boergen K.P. North Carolina macular dystrophy. Hereditary macular disease with good functional prognosis. Der. Ophthal. 1998, 95:13-18.
257. Seddon J.M., Ajani U.A., Mitchell B.D. Familial aggregation of age-related maculopathy. Am. J. Ophthalmol. 1997, 123:199-206.
258. Seddon J.M., Afshari M.A., Sharma S., Bernstein P.S., Chong S., Hutchinson A., Petrukhin K., Allikmets R. Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy. Ophthalmology 2001, 108:2060-2067.
259. Seddon J.M., Sharma S., Adelman R.A. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 2006, 113:260-266.
260. Shiraki K., Kohno T., Moriwaki M., Yanagihara N. Fundus autofluorescence in patients with pseudoxanthoma elasticum. Int. Ophthalmol. 2001, 24:243-248.
261. Shu X., Tulloch B., Lennon A., Vlachantoni D., Zhou X., Hayward C., Wright A.F. Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5. Hum. Mol. Genet. 2006, 15:1680-1689.
262. Sicot G., Gourdon G., Gomes-Pereira M. Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges. Hum. Mol. Genet. 2011, 20:R116-R123.
263. Sivaprasad S., Webster A.R., Egan C.A., Bird A.C., Tufail A. Clinical course and treatment outcomes of Sorsby fundus dystrophy. Am. J. Ophthalmol. 2008, 146:228-234.
264. Sjogren H. Dystrophia reticularis laminae pigmentosae retinae, an earlier not described hereditary eye disease. Acta Ophthalmol. (Copenh) 1950, 28:279-295.
265. Slezak H., Hommer K. Fundus pulverulentus. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 1969, 178:176-182.
266. Smailhodzic D., Fleckenstein M., Theelen T., Boon C.J., van Huet R.A., van de Ven J.P., Den Hollander A.I., Schmitz-Valckenberg S., Hoyng C.B., Weber B.H., Holz F.G., Klevering B.J. Central areolar choroidal dystrophy (CACD) and age-related macular degeneration (AMD): differentiating characteristics in multimodal imaging. Invest. Ophthalmol. Vis. Sci. 2011, 52:8908-8918.
267. Small K.W. North Carolina macular dystrophy, revisited. Ophthalmology 1989, 96:1747-1754.
268. Small K.W. North Carolina macular dystrophy: clinical features, genealogy, and genetic linkage analysis. Trans. Am. Ophthalmol. Soc. 1998, 96:925-961.
269. Small K.W., Killian J., McLean W.C. North Carolina's dominant progressive foveal dystrophy: how progressive is it?. Br. J. Ophthalmol. 1991, 75:401-406.
270. Small K.W., Weber J.L., Roses A., Lennon F., Vance J.M., Pericak-Vance M.A. North Carolina macular dystrophy is assigned to chromosome 6. Genomics 1992, 13:681-685.
271. Small K.W., Voo I., Flannery J., Udar N., Glasgow B.J. North Carolina macular dystrophy: clinicopathologic correlation. Trans. Am. Ophthalmol. Soc. 2001, 99:233-237. Discussion 237-238.
272. Smith W., Assink J., Klein R., Mitchell P., Klaver C.C., Klein B.E., Hofman A., Jensen S., Wang J.J., de Jong P.T. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001, 108:697-704.
273. Sobrin L., Maller J.B., Neale B.M., Reynolds R.C., Fagerness J.A., Daly M.J., Seddon J.M. Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach. Eur. J. Hum. Genet. 2010, 18:496-501.
274. Sohn E.H., Mullins R.F., Stone E.M. Macular dystrophies. Retina 2013, V, Elsevier, London, New York, Oxford, St. Louis, Sydney, Toronto. J.R. Ryan (Ed.).
275. Song I.S., Shin Y.U., Lee B.R. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography. Am. J. Ophthalmol. 2012, 154:366-375. e364.
276. Souied E.H., Pawlak D., Algan M., Sayag D., Coscas G., Soubrane G. Photodynamic therapy for choroidal neovascularization on late-onset fundus flavimaculatus. Am. J. Ophthalmol. 2005, 140:312-314.
277. Souied E.H., Leveziel N., Letien V., Darmon J., Coscas G., Soubrane G. Optical coherent tomography features of malattia leventinese. Am. J. Ophthalmol. 2006, 141:404-407.
278. Souied E.H., Leveziel N., Querques G., Darmon J., Coscas G., Soubrane G. Indocyanine green angiography features of Malattia leventinese. Br. J. Ophthalmol. 2006, 90:296-300.
279. Soumplis V., Sergouniotis P.I., Robson A.G., Michaelides M., Moore A.T., Holder G.E., Webster A.R. Phenotypic findings in C1QTNF5 retinopathy (late-onset retinal degeneration). Acta Ophthalmol. 2013, 91:e191-e195.
280. Spaide R.F., Curcio C.A. Drusen characterization with multimodal imaging. Retina 2010, 30:1441-1454.
281. Spaide R.F., Klancnik J.M. Fundus autofluorescence and central serous chorioretinopathy. Ophthalmology 2005, 112:825-833.
282. Spaide R.F., Noble K., Morgan A., Freund K.B. Vitelliform macular dystrophy. Ophthalmology 2006, 113:1392-1400.
283. Sparrow J.R., Vollmer-Snarr H.R., Zhou J., Jang Y.P., Jockusch S., Itagaki Y., Nakanishi K. A2E-epoxides damage DNA in retinal pigment epithelial cells. Vitamin E and other antioxidants inhibit A2E-epoxide formation. J.Biol. Chem. 2003, 278:18207-18213.
284. Stargardt K. Über familiäre, progressive Degeneration in der Maculagegend des Auges. Graefes Arch. Clin. Exp. Ophthalmol. 1909, 71:534-550.
285. Steinert H. Myopathologische Beitrage 1: Uber das klinischeund anatomische Bild des Muskelschwunds der Myotoniker. Dtsch. Z. Nervenheilkd. 1909, 37:58-104.
286. Stohr H., Anand-Apte B. Areview and update on the molecular basis of pathogenesis of Sorsby fundus dystrophy. Adv. Exp. Med. Biol. 2012, 723:261-267.
287. Stone E.M., Lotery A.J., Munier F.L., Heon E., Piguet B., Guymer R.H., Vandenburgh K., Cousin P., Nishimura D., Swiderski R.E., Silvestri G., Mackey D.A., Hageman G.S., Bird A.C., Sheffield V.C., Schorderet D.F. Asingle EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat. Genet. 1999, 22:199-202.
288. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. Arch. Ophthalmol. 109, 1242-1257.
289. Suter M., Reme C., Grimm C., Wenzel A., Jaattela M., Esser P., Kociok N., Leist M., Richter C. Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J.Biol. Chem. 2000, 275:39625-39630.
290. Suzuki M., Gomi F., Sawa M., Ueno C., Nishida K. Changes in fundus autofluorescence in polypoidal choroidal vasculopathy during 3 years of follow-up. Graefes Arch. Clin. Exp. Ophthalmol. 2013, (Epub ahead of print).
291. Szental J.A., Harper C.A., Baird P.N., Michalova K., Guymer R.H. Sorsby's Fundus Dystrophy: a case report to raise awareness of the disease and potential future treatments. Clin. Exp. Ophthalmol. 2009, 37:325-327.
292. Szlyk J.P., Paliga J., Seiple W., Rabb M.F. Comprehensive functional vision assessment of patients with North Carolina macular dystrophy (MCDR1). Retina (Philadelphia, Pa.) 2005, 25:489-497.
293. Takeuchi T., Hayashi T., Bedell M., Zhang K., Yamada H., Tsuneoka H. Anovel haplotype with the R345W mutation in the EFEMP1 gene associated with autosomal dominant drusen in a Japanese family. Invest. Ophthalmol. Vis. Sci. 2010, 51:1643-1650.
294. Theelen T., Berendschot T.T., Boon C.J., Hoyng C.B., Klevering B.J. Analysis of visual pigment by fundus autofluorescence. Exp. Eye Res. 2008, 86:296-304.
295. Travis G.H., Sutcliffe J.G., Bok D. The retinal degeneration slow (rds) gene product is a photoreceptor disc membrane-associated glycoprotein. Neuron 1991, 6:61-70.
296. Tuppurainen K., Mantyjarvi M. The importance of fluorescein angiography in diagnosing pattern dystrophies of the retinal pigment epithelium. Doc. Ophthalmol. 1994, 87:233-243.
297. Ulbig M.R., Riordan-Eva P., Holz F.G., Rees H.C., Hamilton P.A. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy. Am. J. Ophthalmol. 1993, 116:410-413.
298. Vaclavik V., Tran H.V., Gaillard M.C., Schorderet D.F., Munier F.L. Pattern dystrophy with high intrafamilial variability associated with Y141C mutation in the peripherin/RDS gene and successful treatment of subfoveal CNV related to multifocal pattern type with anti-VEGF (ranibizumab) intravitreal injections. Retina (Philadelphia, Pa.) 2012, 32:1942-1949.
299. van de Ven J.P., Boon C.J., Fauser S., Hoefsloot L.H., Smailhodzic D., Schoenmaker-Koller F., Klevering J., Klaver C.C., den Hollander A.I., Hoyng C.B. Clinical evaluation of 3 families with basal laminar drusen caused by novel mutations in the complement factor H gene. Arch. Ophthalmol. 2012, 130:1038-1047.
300. van de Ven J.P., Smailhodzic D., Boon C.J., Fauser S., Groenewoud J.M., Chong N.V., Hoyng C.B., Klevering B.J., den Hollander A.I. Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration. Mol. Vis. 2012, 18:2271-2278.
301. van de Ven J.P., Nilsson S.C., Tan P.L., Buitendijk G.H., Ristau T., Mohlin F.C., Nabuurs S.B., Schoenmaker-Koller F.E., Smailhodzic D., Campochiaro P.A., Zack D.J., Duvvari M.R., Bakker B., Paun C.C., Boon C.J., Uitterlinden A.G., Liakopoulos S., Klevering B.J., Fauser S., Daha M.R., Katsanis N., Klaver C.C., Blom A.M., Hoyng C.B., den Hollander A.I. Afunctional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat. Gen. 2013, 45:813-817.
302. van den Ouweland J.M., Lemkes H.H., Ruitenbeek W., Sandkuijl L.A., de Vijlder M.F., Struyvenberg P.A., van de Kamp J.J., Maassen J.A. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet. 1992, 1:368-371.
303. Vincent A., Munier F.L., Vandenhoven C.C., Wright T., Westall C.A., Heon E. The characterization of retinal phenotype in a family with C1QTNF5-related late-onset retinal degeneration. Retina (Philadelphia, Pa.) 2012, 32:1643-1651.
304. von Ruckmann A., Schmidt K.G., Fitzke F.W., Bird A.C., Jacobi K.W. Fundus autofluorescence in patients with hereditary macular dystrophies, malattia leventinese, familial dominant and aged-related drusen. Klin. Monbl. Augenheilkd. 1998, 213:81-86.
305. Voo I., Glasgow B.J., Flannery J., Udar N., Small K.W. North Carolina macular dystrophy: clinicopathologic correlation. Am. J. Ophthalmol. 2001, 132:933-935.
306. Wabbels B., Demmler A., Paunescu K., Wegscheider E., Preising M.N., Lorenz B. Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Graefes Arch. Clin. Exp. Ophthalmol. 2006, 244:36-45.
307. Wabbels B., Preising M.N., Kretschmann U., Demmler A., Lorenz B. Genotype-phenotype correlation and longitudinal course in ten families with best vitelliform macular dystrophy. Graefe's Arch. Clin. Exp. Ophthalmol. 2006, 244:1453-1466.
308. Walter P., Widder R.A., Luke C., Konigsfeld P., Brunner R. Electrophysiological abnormalities in age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 1999, 237:962-968.
309. Wang M.S., Sander B., Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am. J. Ophthalmol. 2002, 133:787-793.
310. Wang J.J., Foran S., Smith W., Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch. Ophthalmol. 2003, 121:658-663.
311. Wang M., Munch I.C., Hasler P.W., Prunte C., Larsen M. Central serous chorioretinopathy. Acta Ophthalmol. 2008, 86:126-145.
312. Wang L., Clark M.E., Crossman D.K., Kojima K., Messinger J.D., Mobley J.A., Curcio C.A. Abundant lipid and protein components of drusen. PLoS One 2010, 5:e10329.
313. Weber B.H., Vogt G., Pruett R.C., Stohr H., Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat. Genet. 1994, 8:352-356.
314. Weenink A.C., Borsje R.A., Oosterhuis J.A. Familial chronic central serous chorioretinopathy. Ophthalmologica 2001, 215:183-187.
315. Westeneng-van Haaften S.C., Boon C.J., Cremers F.P., Hoefsloot L.H., den Hollander A.I., Hoyng C.B. Clinical and genetic characteristics of late-onset Stargardt's disease. Ophthalmology 2012, 119:1199-1210.
316. Wickham L., Chen F.K., Lewis G.P., Uppal G.S., Neveu M.M., Wright G.A., Robson A.G., Webster A.R., Grierson I., Hiscott P., Coffey P.J., Holder G.E., Fisher S.K., Da Cruz L. Clinicopathological case series of four patients with inherited macular disease. Invest. Ophthalmol. Vis. Sci. 2009, 50:3553-3561.
317. Williams D.G. C3 nephritic factor and mesangiocapillary glomerulonephritis. Pediatr. Nephrol. 1997, 11:96-98.
318. Yamagishi T., Koizumi H., Yamazaki T., Kinoshita S. Fundus autofluorescence in polypoidal choroidal vasculopathy. Ophthalmology 2012, 119:1650-1657.
319. Yang Z., Li Y., Jiang L., Karan G., Moshfeghi D., O'Connor S., Li X., Yu Z., Lewis H., Zack D., Jacobson S., Zhang K. Anovel RDS/peripherin gene mutation associated with diverse macular phenotypes. Ophthal. Genet. 2004, 25:133-145.
320. Yang Z., Tong Z., Chorich L.J., Pearson E., Yang X., Moore A., Hunt D.M., Zhang K. Clinical characterization and genetic mapping of North Carolina macular dystrophy. Vis. Res. 2008, 48:470-477.
321. Yannuzzi L.A., Shakin J.L., Fisher Y.L., Altomonte M.A. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984, 91:1554-1572.
322. Yannuzzi L.A., Wong D.W., Sforzolini B.S., Goldbaum M., Tang K.C., Spaide R.F., Freund K.B., Slakter J.S., Guyer D.R., Sorenson J.A., Fisher Y., Maberley D., Orlock D.A. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch. Ophthalmol. 1999, 117:1503-1510.
323. Yannuzzi L.A., Negrao S., Iida T., Carvalho C., Rodriguez-Coleman H., Slakter J., Freund K.B., Sorenson J., Orlock D., Borodoker N. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001, 21:416-434.
324. Zhang Y., Marmorstein L.Y. Focus on molecules: fibulin-3 (EFEMP1). Exp. Eye Res. 2010, 90:374-375.
325. Zhang K., Garibaldi D.C., Li Y., Green W.R., Zack D.J. Butterfly-shaped pattern dystrophy: a genetic, clinical, and histopathological report. Arch. Ophthalmol. 2002, 120:485-490.
326. Zhao M., Celerier I., Bousquet E., Jeanny J.C., Jonet L., Savoldelli M., Offret O., Curan A., Farman N., Jaisser F., Behar-Cohen F. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J.Clin. Invest. 2012, 122:2672-2679.
327. Zhou J., Jang Y.P., Kim S.R., Sparrow J.R. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16182-16187.
328. Zhu M., Krilis M., Gillies M.C. The relationship between inner retinal cavitation, photoreceptor disruption, and the integrity of the outer limiting membrane in macular telangiectasia type 2. Retina 2013, 33:1547-1550.
329. Zhuk S.A., Edwards A.O. Peripherin/RDS and VMD2 mutations in macular dystrophies with adult-onset vitelliform lesion. Mol. Vis. 2006, 12:811-815.
330. Zweifel S.A., Spaide R.F., Curcio C.A., Malek G., Imamura Y. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010, 117:303-312. e301.